FDA Approves AstraZeneca's SEROQUEL(R) For Bipolar Depression
Yahoo Finance - -- SEROQUEL is now the first and only single medication approved by the FDA to treat both depressive and manic episodes associated with bipolar disorder -- WILMINGTON, Del., Oct. 20 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN - News ) today
Source: biz.yahoo.com
Depression Related News
KOLD-TV - The physical examination will either diagnosis and/or rule out any medical conditions (such as thyroid disease, cancers or neurologic diseases) that could be causing the depression. Treatment Treatment usually involves medication, psychotherapy or a
Source: www.kold.com
Depression - Diagnosis
HealthCentral.com - Most people who are depressed do not seek psychiatric help and must rely on their family doctor. Unfortunately, it is often difficult for a primary care doctor to recognize the problem if the patient does not bring it up directly. Patients themselves
Source: www.healthcentral.com
Anti-Depressant Safe & Effective for Children
WANE-TV - She and researchers from seven other institutions, including the drug's maker, Pfizer, performed a depression treatment study of nearly 400 children, ages six to 17. These children had all suffered from depression for an average of nearly two years
Source: www.wane.com
Click here for more information about adolescent depression adolescent depression
<< Home